Paucisintomáticos (NYHA I/II): HR 0,51** Menos reingresos: 1 año vivo y fuera del hospital (344 d**; 52% pacientes menos ingresan por causas cardiacas**) Eficiencia Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B).
{}